TDS and UScellular to present at Citi AppsEconomy Conference
Get Alerts TDS Hot Sheet
Join SI Premium – FREE
CHICAGO, Dec. 30, 2021 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and United States Cellular Corporation (NYSE: USM) are jointly presenting at Citi's 2022 Virtual AppsEconomy Conference on January 6, 2022 at 11:00 a.m. EST (10:00 a.m. CST). Laurent C. Therivel, President and CEO – UScellular; James W. Butman, President and CEO – TDS Telecom; Colleen Thompson, Vice President, Corporate Relations – TDS; and Jane W. McCahon, Senior Vice President, Corporate Relations – TDS will attend.
To listen to all presentations, please visit the events and presentations pages of investors.tdsinc.com or investors.uscellular.com. The presentation will be webcast both live and on-demand. It is recommended that you register at least 15 minutes before the start of the presentation to register, download and install any necessary multimedia streaming software.
About TDS
Telephone and Data Systems, Inc. (TDS), a Fortune 1000® company, provides wireless; broadband, video and voice; and hosted and managed services to approximately 6 million connections nationwide through its businesses, UScellular, TDS Telecom, and OneNeck IT Solutions. Founded in 1969 and headquartered in Chicago, TDS employed approximately 8,900 associates as of September 30, 2021.
For more information about TDS and its subsidiaries, visit:
TDS: www.tdsinc.comUScellular: www.uscellular.comTDS Telecom: www.tdstelecom.comOneNeck IT Solutions: www.oneneck.com
View original content:https://www.prnewswire.com/news-releases/tds-and-uscellular-to-present-at-citi-appseconomy-conference-301451682.html
SOURCE Telephone and Data Systems, Inc. and United States Cellular Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Times: How fresh dynamics, fierce competition reshape China's auto market
- Parksy (parksy.com) Mapped Parking Around 12 of America's Biggest Venues: Nearly 2,000 Options Near Madison Square Garden, 18 Near Hard Rock Stadium
- Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share